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This article reviews information regarding the clinical 
significance of antibodies to antigens in the Scianna, Dombrock, 
Colton, Landsteiner-Wiener, Chido/Rodgers, H, Kx, Cromer, 
Gerbich, Knops, Indian, and Ok blood group systems. Like most 
blood group systems, antibodies to many of the antigens in these 
groups are rarely encountered because of the high prevalence 
of the associated antigens in most populations. For many, the 
clinical significance—that is, the potential to cause reduced 
survival of transfused antigen-positive red blood cells or a 
transfusion reaction (e.g., anti-Ge2, anti-H) and/or hemolytic 
disease of the fetus and newborn (e.g., anti-Coa, anti-Ge3)—
has been documented. Some of these antibodies are not always 
clinically significant, and because of the high prevalence of the 
antigen, antigen-negative blood may be extremely difficult to find 
(e.g., anti-LW, anti-Inb). The use of a monocyte monolayer assay 
may be helpful when making transfusion decisions for patients 
with these antibodies. For others, their prevalence is so rare 
that information on the clinical significance of their antibodies 
is not available (e.g., anti-Co4, anti-Ok). Immunohematology 
2018;34:103–108.
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Scianna Blood Group System
The Scianna (SC) blood group system, named in 1974, 
contains seven antigens: five high-prevalence antigens (Sc1, 
Sc3, Sc5, Sc6, and Sc7) and two low-prevalence antigens (Sc2 
and Sc4) (Table 1).1 These antigens result from variants in the 
erythroid membrane-associated protein (ERMAP).2 The Sc 
protein is expressed weakly on leukocytes and other tissues 
such as fetal liver, thymus, lymph nodes, spleen, and bone 
marrow in adults.1
Clinical Significance
SC antibodies are usually IgG and are detected by the 
indirect antiglobulin test (IAT). There are rare cases of 
hemolytic disease with enough information to convincingly 
attribute clinical relevance to SC antibodies (Table 1).3 If 
possible, antigen-negative blood should be selected. SC:–1,2,3 
blood may be available but is extremely rare. Donors being 
SC:–1,–2,–3 are not available.4
Antibodies to the two low-prevalence antigens, Sc2 and 
Sc4, have not been reported to cause hemolytic transfusion 
reactions (HTRs). However, they have been implicated in 
hemolytic disease of the fetus and newborn (HDFN). In the 
case of transfusion, IAT-compatible blood (most donors) 
should be selected.2
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Table 1. Antigen and antibody characteristics of the Scianna 
blood group system
Antigen Antibody
ISBT name Trivial name Prevalence HTR HDFN
SC1 Sc1 High No report No report (DAT+)
SC2 Sc2 Low No No to Mild  
(1 case) (DAT+)
SC3 Sc3 High No to mild/
delayed
Mild
SC4 Rd Low No Mild to severe
SC5 STAR High No report No report
SC6 SCER High No report No report
SC7 SCAN High Yes, delayed  
(1 case)
No report
ISBT = International Society of Blood Transfusion; HTR = hemolytic 
transfusion reaction; HDFN = hemolytic disease of the fetus and newborn; 
DAT = direct antiglobulin test.
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Dombrock Blood Group System
Besides the two antithetical antigens, Doa and Dob, the 
Dombrock blood group system (DO) contains eight antigens of 
high prevalence: Gya, Hy, Joa, DOYA, DOMR, DOLG, DOLC, 
and DODE (Table 2).1,5,6 Doa and Dob are polymorphic with 
a prevalence of 67 and 82 percent, respectively, in Caucasian 
individuals. DO is a glycoprotein attached to the red blood cell 
(RBC) membrane by a glycosylphosphatidylinositol anchor.5
Clinical Significance
Anti-Doa and -Dob have caused immediate and delayed 
HTRs, but no clinical HDFN (Table 2).1 They are mostly 
found in sera containing multiple RBC antibodies and often 
disappear in vivo. Anti-Doa and -Dob are usually IgG-reacting, 
optimally by the IAT using papain-treated RBCs.
For blood transfusion, antigen-negative blood should be 
selected.4 Because of the lack of reliable anti-Do antisera, it used 
to be difficult to find compatible blood. With today’s approach 
of molecular testing of donors, compatible donors are more 
easily found. Note, though, that the presence of other antibody 
specificities may complicate the finding of compatible blood.
Anti-Gya, -Hy, -Joa, and other DO antibodies are rare but 
have been reported to cause HTRs. Because of the rarity of 
these antibodies, evidence of clinical significance is limited 
(Table 2).5 Serologically least-incompatible RBC units are 
recommended for patients with weak examples of the antibody, 
but antigen-negative RBCs should be provided for patients 
who demonstrate strong examples of the antibody.4 
Colton Blood Group System
The Colton blood group system (CO) consists of three high-
prevalence antigens (Coa, Co3, and Co4) and one polymorphic 
antigen (Cob) (Table 3). The water channel-forming protein, 
aquaporin-1, is the carrier of the CO blood group antigens.1
Clinical Significance
Anti-Coa has caused delayed HTRs and severe HDFN, 
and patients with anti-Coa should be transfused with Co(a–) 
blood.4
Whereas anti-Coa is often seen as a single specificity, 
anti-Cob is not. This rare antibody, detecting an antigen with 
a prevalence of about 10 percent,1 has been reported to cause 
both acute HTR and a mild delayed HTR (Table 3).7 About 90 
percent of the donors are IAT compatible; these donor RBC 
units should be selected in case of a transfusion. There are 
no reports of anti-Cob being implicated in a serious HDFN, 
although mild HDFN has been reported.1
Anti-Co3 and anti-Co4 are rare antibodies detecting 
antigens of very high prevalence (Table 3). Anti-Co3 has caused 
a mild HTR and serious HDFN. Only four Co4– probands 
have been identified, and because of the rarity of anti-Co4, no 
data are available on its clinical significance.1 Co(a–b–) blood 
should be selected for compatibility testing, but because it is 
extremely rare serologically, least incompatible blood may be 
given with extra caution.4 
Table 2. Antigen and antibody characteristics of the Dombrock 
blood group system
Antigen Antibody
ISBT name Trivial name Prevalence HTR HDFN
DO1 Doa Polymorphic Yes; I/D No report (DAT+)
DO2 Dob Polymorphic Yes; I/D No report (DAT+)
DO3 Gya High No to moderate; 
D
No report (DAT+)
DO4 Hy High No to moderate; 
D
No report (DAT+)
DO5 Joa High No to moderate; 
D
No report





DO7 DOMR High No report No report
DO8 DOLG High No report No report
DO9 DOLC High No report No report
DO10 DODE High No report No report
ISBT = International Society of Blood Transfusion; HTR = hemolytic 
transfusion reaction; HDFN = hemolytic disease of the fetus and newborn;  
I = immediate; D = delayed; DAT = direct antiglobulin test.
Table 3. Antigen and antibody characteristics of the Colton blood 
group system
Antigen Antibody
ISBT name Trivial name Prevalence HTR HDFN
CO1 Coa High No to moderate/ 
D or I/H
Mild to severe
CO2 Cob Polymorphic No to moderate/
D/H
Mild
CO3 Co3 High Mild; H Severe
CO4 Co4 High No report No report
ISBT = International Society of Blood Transfusion; HTR = hemolytic 
transfusion reaction; HDFN = hemolytic disease of the fetus and newborn;  
D = delayed; I = immediate; H = hemolytic.
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Landsteiner-Wiener Blood Group System
Currently, there are three antigens assigned to the 
Landsteiner-Wiener blood group system (LW): LWa, LWab, and 
LWb (Table 4).1 The LW antigens are carried on an intracellular 
adhesion molecule, glycoprotein ICAM-4.7 LWa and LWb are 
antithetical, with LWa being of high prevalence (100%) and 
LWb being of low prevalence (<1%) in most populations. The 
prevalence of LWb is greatest in the Baltic region (e.g., 8% in 
Estonians, 6% in Finns), and thus the likelihood of finding 
LW(a−) donors is greatest in these areas.1 
Autoantibodies developed after antigen suppression are 
not uncommon, which makes the differentiation between allo- 
and autoantibodies difficult.
Clinical Significance
LW antibodies are usually IgG and are detected by the 
IAT. Mild cases of HTR and HDFN with anti-LWa, anti-LWab, 
and anti-LWb have been reported (Table 4).1 For transfusion, 
antigen-negative blood is not required, but D– blood should be 
selected if possible, since the antigen expression is lower than 
that of D+ blood. In the presence of anti-LWb, IAT-compatible 
blood should be selected.4
Chido/Rodgers Blood Group System
The antigens of the Chido/Rodgers blood group system 
(CH/RG) are carried on the C4d fragment of complement 
component C4; Ch antigens are carried on the C4B allotype 
and Rg antigens are carried on the C4A allotype.1 These 
antigens adsorb onto the RBC surface in vivo.1,8 Currently, 
nine antigens have been identified in the CH/RG system: six of 
high prevalence and one that is polymorphic for CH and two 
of high prevalence for RG (Table 5).
Clinical Significance
Anti-Ch and anti-Rg have not been found to cause an HTR 
or HDFN (Table 5).2 Antigen-negative blood is not required for 
transfusion. Severe anaphylactic reactions have been reported 
in a few patients with antibodies to Ch or Rg antigens after 
infusion of plasma products and platelet concentrates since 
these contain soluble Ch/Rg antigen; however; these events 
are exceptional.8
H Blood Group System
The H blood group system contains only one antigen, H. 
The H antigen is present in all individuals except those with the 
Bombay (Oh) phenotype. Individuals with the para-Bombay 
(Ah or Bh) phenotype have very low levels of H (Table 6).1
Clinical Significance
Individuals with the Oh phenotype (RBC H-deficient, 
non-secretor) always have anti-H in their serum/plasma. Like 
anti-A and -B, anti-H is likely to cause a severe immediate 
HTR. HDFN may occur, but there are no reports (Table 6).1 
In case of transfusion, blood of the Oh phenotype must be 
selected.
Individuals with the non-secretor Ah or Bh phenotype 
usually have anti-H in their serum/plasma, although often 
of lower titer. There is little information on the clinical 
ISBT conference—clinical significance of antibodies
Table 4. Antigen and antibody characteristics of the Landsteiner-
Wiener blood group system
Antigen Antibody
ISBT name Trivial name Prevalence HTR HDFN
LW5 LWa High No to mild; D No to mild
LW6 LWab High No report Mild
LW7 LWb Low No to mild No to mild
ISBT = International Society of Blood Transfusion; HTR = hemolytic 
transfusion reaction; HDFN = hemolytic disease of the fetus and newborn; 
D = delayed.
Table 5. Antigen and antibody characteristics of the CH/RG blood 
group system
Antigen Antibody
ISBT name Trivial name Prevalence HTR HDFN
CH/RG1 Ch1 High No hemolytic No report
CH/RG2 Ch2 High No report No report
CH/RG11 Rg1 High No hemolytic No report
CH/RG12 Rg2 High No report No report
Five additional antigens within the CH/RG blood group system have been 
identified but with no information.1
ISBT = International Society of Blood Transfusion; HTR = hemolytic 
transfusion reaction; HDFN = hemolytic disease of the fetus and newborn.
Table 6. Antigen and antibody characteristics of the H blood 
group system
Antigen Antibody
ISBT name Trivial name Prevalence HTR HDFN
H H High No to severe; 
I/D/H
No report
ISBT = International Society of Blood Transfusion; HTR = hemolytic 
transfusion reaction; HDFN = hemolytic disease of the fetus and newborn;  
I = immediate; D = delayed; H = hemolytic.
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significance of anti-H in Ah or Bh individuals. Preferably, blood 
of the Oh phenotype should be transfused, but if not available, 
then RBCs of the appropriate ABO group (A for Ah, B for Bh) 
may be transfused with extra caution.4 
Individuals with the secretor Ah or Bh phenotype may 
have anti-HI present in their serum/plasma. Typically, anti-HI 
is not reactive at 37°C, and ABO-identical blood, compatible at 
37°C, can be used for transfusion.4
Anti-HI may also be found in group A1, A1B, or B 
individuals. If the antibody is reactive at 37°C, blood of the 
ABO group of the patient should be used for transfusion; 
blood of group O and A2 should not be used. If the antibody is 
reactive only at lower temperatures, blood compatible at 37°C 
can be used for transfusion, regardless of ABO group.4
Kx Blood Group System
Kx was assigned blood group system status in 1990 
and contains one antigen of very high prevalence (100%), 
Kx (Table 7). The Kx antigen is covalently linked to the 
Kell molecule on RBCs and is controlled by a gene on the 
X chromosome. The presence of the Kx protein is critical 
to normal RBC morphology, and silencing mutations are 
associated with McLeod syndrome, neuroacanthocytosis, and 
neuromuscular disorders in later life.9
Clinical Significance
Anti-Kx is often found together with anti-Km (anti-
KEL20) in men with the McLeod phenotype and X-linked 
chronic granulomatous disease. These two antibodies (also 
called anti-KL) can cause severe HTRs; thus, antigen-negative 
(McLeod phenotype) blood should be selected for transfusion 
(Table 7).4
Gerbich Blood Group System
The Gerbich blood group system is expressed on 
glycophorin C and D and contains 11 antigens: 6 of high 
prevalence and 5 of low prevalence (Table 8).10
Clinical Significance
Anti-Ge2, made by Yus, Gerbich, or Leach phenotypes, 
and anti-Ge3, made by Gerbich or Leach phenotypes, are 
usually IgG antibodies and can cause moderate immediate or 
delayed HTRs. Anti-Ge4 (made by Leach phenotypes), -GEPL, 
-GEAT, and -GETI are very rare, and no data are available on 
their clinical significance (Table 8).10 Antigen-negative blood is 
not usually required for transfusion but should be considered 
for strong examples of these antibodies.4
Although Anti-Ge2 has not been implicated in clinical 
HDFN, newborns have shown positive direct antiglobulin 
tests (DATs).1 Anti-Ge3 has caused severe HDFN due to 
suppression of the erythroid progenitor cell growth in the 
infant. Initial treatment of the infant at birth with subsequent 
follow-up for several weeks after birth may be indicated.1 
There is no information on the clinical significance with regard 
to HDFN for anti-Ge4, -GEPL, -GEAT, and -GETI.1
The antibodies to the low-prevalence antigens of the 
Gerbich system can be naturally occurring and may be IgM 
S. Lejon Crottet
Table 7. Antigen and antibody characteristics of the Kx blood 
group system
Antigen Antibody
ISBT name Trivial name Prevalence HTR HDFN
XK1 Kx High Mild; D Not applicable*
*Anti-Kx only made by male individuals with McLeod phenotype
ISBT = International Society of Blood Transfusion; HTR = hemolytic 
transfusion reaction; HDFN = hemolytic disease of the fetus and newborn; 
D = delayed.
Table 8. Antigen and antibody characteristics of the Gerbich 
blood group system
Antigen Antibody
ISBT name Trivial name Prevalence HTR HDFN
GE2 Ge2 High No to moderate; 
I/D
No report  
(DAT+)
GE3 Ge3 High No to moderate; 
I/D
Positive DAT  
to severe
GE4 Ge4 High No report No report
GE5 Wb Low No report No report
GE6 Lsa Low No report No report
GE7 Ana Low No report No report
GE8 Dha Low No report 1 report,  
very severe
GE9 GEIS Low No report No report
GE10 GEPL High No report No report
GE11 GEAT High No report No report
GE12 GETI High No report No report
ISBT = International Society of Blood Transfusion; HTR = hemolytic 
transfusion reaction; HDFN = hemolytic disease of the fetus and newborn;  
I = immediate; D = delayed; DAT = direct antiglobulin test.
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or IgG. There are no reports that these antibodies have caused 
HTRs or HDFN.1
Cromer Blood Group System
The antigens of the Cromer blood group system are carried 
on the decay accelerating factor (DAF), a protein belonging 
to the regulators of the complement activation family. The 
system contains 16 high-prevalence antigens and three low-
prevalence antigens (Table 9).11
Clinical Significance
Antibodies to Cromer antigens are rare (Table 9). 
There is evidence that the antibodies may cause accelerated 
destruction of transfused RBCs, although functional assays 
on clinical significance are ambiguous.11 Because of the high 
concentration of maternal DAF on the apical surface of the 
trophoblasts in the placenta, which is thought to adsorb the 
maternal antibodies, there is no risk of HDFN associated 
with Cromer system antibodies. Antigen-negative blood is not 
usually required for transfusion, but should be considered for 
strong-reacting antibodies.4
Knops Blood Group System
The antigens of the Knops blood group system are carried 
on complement receptor 1 (CR1). The major functions of CR1 
are the binding of C4b/C3b opsonized complexes as well 
as complement regulation. The Knops blood group system 
contains nine antigens that are polymorphic, of low prevalence 
or of high prevalence depending on the origin of the individual 
(Table 10).1,12
Clinical Significance
Most of the Knops antibodies are not considered clinically 
significant since they do not cause apparent HTRs or HDFN, 
thus antigen-negative units are not indicated in the case of 
transfusion (Table 10).4
Indian Blood Group System
The Indian blood group system contains four antigens 
that are carried by CD44. Ina and Inb are antithetical antigens 
of low prevalence and high prevalence, respectively. INFI and 
INJA are both antigens of high prevalence (Table 11).2
Table 9. Antigen and antibody characteristics of the Cromer blood 
group system
Antigen Antibody
ISBT name Trivial name Prevalence HTR HDFN*
CROM1 Cra High No to moderate No
CROM2 Tca High No to severe No
CROM3 Tcb Low No report No report
CROM4 Tcc Low No to mild No
CROM5 Dra High No to mild No
CROM6 Esa High Mild No
CROM7 IFC High No to mild No
CROM8 WESa Low No to mild No
CROM9 WESb High No report No, DAT+
CROM10 UMC High No report No
CROM11 GUTI High No report No
CROM12 SERF High No data No 
CROM13 ZENA High No data No
CROM14 CROV High No data No
CROM15 CRAM High No data No
CROM16 CROZ High No data No
*Decay accelerating factor adsorbs maternal antibody
ISBT = International Society of Blood Transfusion; HTR = hemolytic 
transfusion reaction; HDFN = hemolytic disease of the fetus and newborn; 
DAT = direct antiglobulin test.
Table 10. Antigen and antibody characteristics of the Knops blood 
group system
Antigen Antibody
ISBT name Trivial name Prevalence HTR HDFN
KN1 Kna High No No
KN2 Knb Low No report No report
KN3 McCa High No No




No to mild No
KN5 Yka High No No




No report,  
unlikely
No report




No report,  
unlikely
No report
KN8 Sl3 High No report,  
unlikely
No report




No report,  
unlikely
No report
ISBT = International Society of Blood Transfusion; HTR = hemolytic 
transfusion reaction; HDFN = hemolytic disease of the fetus and newborn.
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Clinical Significance
Indian antibodies are mostly IgG, reacting preferably by 
the IAT (Table 11). These antibodies do not bind complement 
and do not cause in vitro hemolysis.6 Ina is rare in populations 
of European origin, but has a prevalence of about 3 percent in 
Indian individuals and 10 percent in Arab individuals. Anti-
Ina is not reported to be clinically significant, although limited 
data are available. Blood compatible by IAT can be selected for 
transfusion.4
Anti-Inb may cause none to severe/delayed HTRs.1 In(b–) 
blood is not usually required for transfusion but should be 
considered for strong-reacting antibodies.
No clinical data are available on anti-INFI and anti-
INJA; INFI– and INJA– blood types are extremely rare. For 
transfusion, serologically least-incompatible blood should be 
used with extra caution.4
Anti-Ina, -Inb, and -INJA have not been implicated in 
HDFN.1 Anti-INFI was implicated in one case of mild HDFN.13
Ok Blood Group System
The Ok blood group system contains three antigens 
carried on CD147 (Table 12).14 The Ok blood group system was 
established in 1999. To date, the null phenotype, Ok(a–) has 
been found in eight Japanese families only.
Clinical Significance
Ok antibodies have not been implicated in HDFN.1 There 
is almost no information on the clinical significance of Ok 
antibodies, but in vivo survival tests and cellular functional 
assays suggest that anti-Oka is clinically significant (Table 
12).1 Because Ok(a–) blood is extremely rare, serologically 
least-incompatible blood may be given with extra caution.4
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Table 11. Antigen and antibody characteristics of the Indian blood 
group system
Antigen Antibody
ISBT name Trivial name Prevalence HTR HDFN
IN1 Ina Low Decreased cell 
survival
No, DAT+
IN2 Inb High No to severe D No, DAT+
IN3 INFI High No report Mild
IN4 INJA High No report No report
ISBT = International Society of Blood Transfusion; HTR = hemolytic 
transfusion reaction; HDFN = hemolytic disease of the fetus and newborn; 
DAT = direct antiglobulin test; D = delayed.
Table 12. Antigen and antibody characteristics of the Ok blood 
group system
Antigen Antibody
ISBT name Trivial name Prevalence HTR HDFN
OK1 Oka High 51Cr cell  
survival reduced
No
OK2 OKGV High No report No report
OK3 OKVM High No report No report
ISBT = International Society of Blood Transfusion; HTR = hemolytic 
transfusion reaction; HDFN = hemolytic disease of the fetus and newborn.
